A new approach combining intraocular transplantation and confocal microscopy enables longitudinal, non-invasive real-time imaging with single-cell resolution within grafted tissues in vivo. We demonstrate how to transplant pancreatic islets into the anterior chamber of the mouse eye.
Intravital imaging has emerged as an indispensable tool in biological research. In the process, many imaging techniques have been developed to study different biological processes in animals non-invasively. However, a major technical limitation in existing intravital imaging modalities is the inability to combine non-invasive, longitudinal imaging with single-cell resolution capabilities. We show here how transplantation into the anterior chamber of the eye circumvents such significant limitation offering a versatile experimental platform that enables non-invasive, longitudinal imaging with cellular resolution in vivo. We demonstrate the transplantation procedure in the mouse and provide representative results using a model with clinical relevance, namely pancreatic islet transplantation. In addition to enabling direct visualization in a variety of tissues transplanted into the anterior chamber of the eye, this approach provides a platform to screen drugs by performing long-term follow up and monitoring in target tissues. Because of its versatility, tissue/cell transplantation into the anterior chamber of the eye not only benefits transplantation therapies, it extends to other in vivo applications to study physiological and pathophysiological processes such as signal transduction and cancer or autoimmune disease development.
Advances in intravital microscopy have revealed physiological phenomena not predicted by in vitro studies1. This highlights the challenge in translating findings obtained by conventional in vitro methods into the living animal. In the last decade, visualization of tissues in living animals was considerably improved by technological advances in imaging modalities2, 3, 4, 5, 6. This has spurred a need for in vivo imaging approaches with feasible application in experimental animal models to enable longitudinal visualization of target tissues non-invasively.
Imaging techniques such as magnetic resonance imaging and positron emission tomography or bioluminescence have enabled non-invasive imaging of organs/tissues deep within the body7-8, 9. But these techniques cannot achieve single cell-resolution due to high background signals and low spatial resolution, despite the use of high contrast materials or tissue-specific luminescence4. This was addressed with the advent of two-photon fluorescence confocal microscopy10. Two-photon microscopy enabled intravital imaging studies to visualize and quantify cellular events with unprecedented details11, 12. This has led to the characterization of key biological processes in health and disease13, 14, 15, 16. While pioneering intravital imaging studies have primarily “mimicked” in vivo conditions in excised tissue (e.g. lymph nodes), other studies have used invasive approaches to image exposed target tissues in situ17, 18, 19, 20, 21. Other studies have also used “window chamber models” to circumvent limitations associated with invasive approaches and limited imaging resolution in vivo22, 23, 24, 25. In the window chamber model, a chamber with a transparent window is surgically implanted into the skin at different locations (dorsal or ear skin, mammary fat pad, liver, etc) on the animal (e.g. mouse, rat, rabbit). While this approach clearly enables high-resolution in vivo imaging, it requires an invasive surgery to implant the chamber and may not be able to accommodate longitudinal imaging studies over several weeks or months22.
It was recently demonstrated that combining high-resolution confocal microscopy with a minimally invasive procedure, namely transplantation into the anterior chamber of the eye (ACE) provides a “natural body window” as a powerful and versatile in vivo imaging platform26, 27. Transplantation into the ACE has been used in the last several decades to study biological aspects of a variety of tissues 28, 29, 30; and its recent combination with high-resolution imaging enabled studying the physiology of pancreatic islets with single cell-resolution non-invasively and longitudinally26, 27. This approach was used to study autoimmune responses during development of type 1 diabetes in animal models (unpublished data). It was also used to study pancreatic development, as well as, in studies of kidney function by transplanting into the ACE pancreatic buds or individual renal glomeruli, respectively (unpublished data). A recent report using this approach further demonstrated its application to study immune responses after pancreatic islet transplantation31. Importantly, this study showed that transplantation into the anterior chamber of the eye provides a natural body window to perform: (1) longitudinal, non-invasive imaging of transplanted tissues in vivo; (2) in vivo cytolabeling to assess cellular phenotype and viability in situ; (3) real-time tracking of infiltrating immune cells in the target tissue; and (4) local intervention by topical application or intraocular injection.
Here, we demonstrate how to perform transplantation into the anterior chamber of the eye using pancreatic islets.
The following procedure is performed under the stereoscope in 2 steps, the first step involves loading the islets into the cannula and the second step is the actual transplantation into the ACE. All procedures performed on animals were approved by the institutional animal care and use committee (IACUC) of the University of Miami.
1. Loading Islets in Cannula for Transplantation
2. Islet Transplantation into the Anterior Chamber of the Eye
There are a few parameters that define a “good” transplantation. A good transplantation is one that proceeds without bleeding when making the incision as can be seen in the video. Bleeding is prevented/minimized by penetrating only the tip of the scalpel (needle) into the ACE (Figure 3a). This will also help prevent contact and puncture of the iris. It will also ensure a small incision which will heal very well without causing cloudiness of the cornea over time (Figure 3c, d). Another important aspect to a successful transplantation is to be able to transplant the total desired amount of islets without loss due to reflux out of the ACE. As mentioned in the protocol step 1.6, this can be minimized by ejecting the islets in the least possible volume and, when applicable, by using air bubbles to help seal the incision upon final retraction of the cannula out of the ACE (Figure 3b). Moreover, delivering the islets on top of the iris between the edge of the pupil and the limbus positions the islets in a location very amenable for in vivo imaging (Figure 3d). From practical perspective, having the islets at this intermediate position of the iris reduces the thickness of the imaging z-stacks required to span whole islets (Figure 4). This is particularly important during fluorescence confocal/two-photon in vivo imaging where a smaller z-stack allows better recovery of specific fluorescence signals in deeper sections of the imaged tissue with better xy and z resolutions due to less light scatter by the tissue. Moreover, thicker z-stacks require longer acquisition time which increases the likelihood of instrumental or animal drift, especially during in vivo imaging.
Figure 1. Photographs of our transplantation apparatus including all parts. (a) Assembled glass syringe with tubing, reservoir, and cannula. (b) Motorized syringe-driver with syringe mounted. (c) Dual foot pedal to operate the motorized syringe driver. Pressing either pedal drives the syringe plunger backward (aspiration) or forward (ejection). (d) Close-up of the cannula and connecting tubing showing the islets packed at the back of the cannula. This configuration allows delivery of the islets into the anterior chamber of the eye in a minimal volume to reduce reflux and loss of islets.
Figure 2. Depiction of the transplantation procedure into the anterior chamber of the eye (ACE). (a) Photograph of the mouse anesthesia mask. (b) Close-up view of the anesthesia mask made of a 1 ml disposable plastic pipette tip without filter. Several holes were made in the tip to allow mixing of oxygen with isoflurane before reaching the mouse. (c) Close-up view showing the eye to be transplanted exposed for better access. The eye is exposed out by stretching the skin of the head using the thumb and index finger. (d) Schematic depiction of the transplantation procedure highlighting the location of the incision at midpoint between the apex of the cornea and the limbus. The cannula is inserted through the incision to deliver the islets into the ACE. Islets are deposited on top of the iris where they engraft.
Figure 3. Representative images of “good” transplantation highlighting critical steps in ensuring successful outcomes. (a) Series of images showing how far the tip of the scalpel (needle) is pushed into the cornea while making the incision. A small incision is made without bleeding. The incision is slightly larger than the cannula. (b) Series of images showing islets being ejected out of the cannula on top of the iris while using air bubbles to prevent reflux. Notice how “bent” the cannula appears due to light refraction once inside the ACE. (c) Representative image of a transplanted eye highlighting the clarity of the ACE immediately after transplantation. (d) Series of images of the same eye acquired on the specified post-operative days (POD) highlighting the preferred location of islets for in vivo imaging and how well-healed and localized the incision is and the clarity of the cornea at 6 weeks after transplantation.
Figure 4. Representative fluorescence confocal image of a pancreatic islet transplanted in the anterior chamber of the mouse eye (ACE) highlighting the benefits of the islet position on the iris and the ability to resolve individual cells during in vivo imaging. (a) Maximum projection (2-D view) of a z-stack of an islet (outlined with dotted line) on top of the iris of a C57BL/6 transgenic mouse that expresses green fluorescent protein (GFP) in activated and memory T-cells 32. The image was acquired 5 days after transplantation where a few infiltrating T-cells (green) were detected in the iris surrounding the islet. The islet and iris were visualized by laser backscatter or reflection (grey). (b) Three-dimensional (3-D) views of the same islet highlighting the benefits of viewing/imaging angle to reduce the z-stack thickness to acquire the whole islet volume and surrounding structure and immune cells. Notice the xyz axes for rotation of the image.
Murine pancreatic islets were isolated using collagenase digestion followed by purification on density gradients, as described previously 33. Isolated islets were cultured overnight before transplantation. While this may not be required, it is recommended to allow the islets to recover from the isolation procedure. This is critical when transplantation is performed in diabetic recipients as it will ensure transplantation of surviving/robust islets.
Transplantation is performed under generalized anesthesia with oxygen/isoflurane mixture (1.5-3%) inhalation to effect. Alternative inhalation or injection anesthetics (e.g. ketamine) can be used. If injection anesthesia is used, skip step 2.2 in the protocol. Provide the anesthetized animal with a source of heat to prevent hypothermia during the procedure. In some mice, it is possible to break blood vessels when making the incision in the typically avascular cornea. For example, the cornea of nude mice tends to be vascularized; avoid vascularized areas when possible. Use a new syringe per incision. Avoid puncturing the iris with the needle when making the incision. Preventing contact with the iris can be further ensured by facing the beveled side of the needle tip toward the iris. Do not dry/aspirate aqueous humor after making the incision. It is easier to penetrate the cannula through the incision in a “wet” cornea; add a few drops of sterile PBS or culture media to the cornea if needed.
Post-operative analgesia can be obtained by injecting subcutaneously buprenorphine (0.05-0.1 mg/kg) or preferred analgesic(s) for the first 48 hr. In step 2.9, we administer analgesia immediately after the procedure as the animal is already deeply under general anesthesia. If desired, however, step 2.9 can be performed after step 2.2 in the protocol, with or without a topical anesthetic to the eye (consult with your local IACUC or veterinarian). Alternative ophthalmic antibiotics can also be used.
Here, we used a custom-built microinjection apparatus operated via a foot pedal to drive the 100 μl precision glass syringe to aspirate (load) and eject the islets out of the cannula into the ACE (Figure 1). This can be substituted with any 100 μl gas-tight precision glass syringe with a screw-driven plunger that can be operated manually to aspirate/eject the islets; this however will likely require the assistance of another person to operate. In either case, although not required we recommend pre-loading the assembled syringe, tubing, and reservoir with a sterile solution (saline, PBS or culture media) to ensure smooth aspiration and ejection of the islets. This is particularly important if/when the packed islets clog the cannula.
We typically perform our transplantation procedures under clean conditions inside a biosafety cabinet without risk of infections. All used solutions, syringes, cannula, tubing, and gauze are autoclaved or gas-sterilized. While, we cannot ascertain full sterility because of hand contact with the mouse during the procedure, we have not had any issues with islet contamination following the above recommended steps.
We demonstrated here how to transplant pancreatic islets into the ACE for imaging purposes where fewer islets are needed to transplant. In the case where diabetes reversal is desired in the recipient animal, a larger amount of islets needs to be transplanted 26, 27. While the transplantation procedure is identical to what we showed here, particular attention should be paid to steps 2.6 and 2.7 in the protocol to avoid loss of transplanted islets due to reflux.
Once mastered, this transplantation procedure can be performed in ~ 5 min per mouse. This technique can be used to transplant a variety of tissues into the anterior chamber of the eye. As mentioned above, we have transplanted renal glomeruli as well as embryonic tissue (pancreatic buds) to study pancreatic development in the anterior chamber of the eye in vivo.
The authors have nothing to disclose.
We acknowledge Drs. Camillo Ricordi, Antonello Pileggi, R. Damaris Molano, Stephan Speier and Daniel Nyqvist for fruitful discussions. We also thank Eleut Hernandez and Diego Espinosa-Heidmann for technical assistance, and Mike Valdes and Margaret Formoso for help with video recording. Byron Maldonado recorded, edited, and produced the final video. Research support was provided by the Diabetes Research Institute Foundation (www.DiabetesResearch.org), the NIH/NIDDK/NIAID (F32DK083226 to M.H.A.; NIH RO3DK075487 to A.C.; U01DK089538 to P-O.B.). Additional research support to P-O.B was provided through funds from the Karolinska Institutet, the Swedish Research Council, the Swedish Diabetes Foundation, the Family Erling-Persson Foundation, the Family Knut and Alice Wallenberg Foundation, the Skandia Insurance Company Ltd., VIBRANT (FP7-228933-2), Strategic Research Program in Diabetes at Karolinska Institutet, the Novo Nordisk Foundation, and the Berth von Kantzow’s Foundation.
Name of reagent | Company | Catalogue number | Description/Comments |
IsoTHESIA (Isoflurane) | Buttler Animal Health Supply | 11695-6775-2 | 99.9% Isoflurane/ml |
Ketaset (Ketamine HCL) | Fort dodge Animal Health | 0856-2013-01 | Alternative injectable anesthesia |
Beprenex (Buprenorphine HCL) | Reckitt Benckiser Health Care (UK) Ltd. | 12496-075-7-1 | 0.3 mg/ml |
Erythromycin Ophthalmic Ointment USP, 0.5% | Akron | 17478-070-35 | Applied prophylactically to transplanted eye |
0.9% Sodium Chloride (Saline) | Hospira Inc. | 0409-7983-03 | For iv injection. Sterile |
PBS | Gibco | 10010-023 | 1X. Sterile |
CMRL medium 1066 | Cellgro | 98-304-CV | Supplemented, CIT modification. Preferred media for islets |